All you need to know about International Mutual Funds
All you need to know about International Mutual Funds

All you need to know about International Mutual Funds

Henil Shah Article rating: 4.5

The advantages of diversification is a much talked topic in the investor community. Diversification is one of the key tools for mitigating risk. Diversification means investing in unrelated asset classes. Investors may also further diversify their portfolio by spreading risk across geographies.

Government bans sale of 328 fixed-dose combinations
Government bans sale of 328 fixed-dose combinations

Government bans sale of 328 fixed-dose combinations

Gayathri Udyawar Article rating: 5.0

Health Ministry has prohibited the manufacture and sale of 328 fixed-dose combinations (FDCs) for human use with immediate effect observing that they may involve risk to patients.

Wipro partners with Duck Creek Technologies
Wipro partners with Duck Creek Technologies

Wipro partners with Duck Creek Technologies

Dnyanada Kulkarni Article rating: 3.1

Soap-to-software company Wipro gained after the company announced a partnership with Duck Creek Technologies, developer of software for property and casualty insurers across the globe. The partnership arrangement is such that Wipro will provide a multitude of implementation services and associated software and data solutions to insurance companies. 

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on September 12, 2018 opened up. BSE Sensex is trading at 37,377.19, down by 35.94 points and the Nifty is trading at 11,264.25, down by 23.25 points. 

Sun Pharma falls as USFDA investigates Mohali plant
Sun Pharma falls as USFDA investigates Mohali plant

Sun Pharma falls as USFDA investigates Mohali plant

Dnyanada Kulkarni Article rating: 4.3

Sun Pharma’s Mohali plant in Punjab is undergoing a three-day surprise investigation by the USFDA. The investigation commenced on September 10, 2018, confirmed the company in an exchange filing. The company is of the opinion that the investigation will not cause any material impact.

Antiretroviral drug of Cipla receives approval from South African regulator
Antiretroviral drug of Cipla receives approval from South African regulator

Antiretroviral drug of Cipla receives approval from South African regulator

Gayathri Udyawar Article rating: 5.0

Cipla’s first-line triple-combination treatment for HIV receives approval from the South African Health Products Regulatory Authority (SAHPRA). The newly developed combination drug will be produced locally for the African market.

Narayana Hrudayalaya gains as arm ties-up with Bangladesh-based hospital
Narayana Hrudayalaya gains as arm ties-up with Bangladesh-based hospital

Narayana Hrudayalaya gains as arm ties-up with Bangladesh-based hospital

Sanket Dewarkar Article rating: 2.5

Narayana Hrudayalaya’s step-down subsidiary, NH Health Bangladesh, has entered into definitive agreements to partner with Imperial Hospital in Chittagong, Bangladesh to operate and manage their cardiac sciences department.

RSS
First33213322332333243326332833293330Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR